Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reconstructive surgery after female genital mutilation.
Zhang GY, Li QF, Cai JL, Fu XB, Gao WY. Zhang GY, et al. Among authors: cai jl. Lancet. 2012 Oct 27;380(9852):1468-9; author reply 1469-70. doi: 10.1016/S0140-6736(12)61835-2. Lancet. 2012. PMID: 23101709 No abstract available.
Tyrosine kinase inhibitor maintenance following chimeric antigen receptor T-cell therapy in Philadelphia chromosome-positive acute lymphoblastic leukaemia.
Othman T, Koller P, Pourhassan H, Agrawal V, Ngo D, Tinajero J, Ali H, Cai JL, Mei M, Aribi A, Stein AS, Marcucci G, Forman SJ, Pullarkat V, Aldoss I. Othman T, et al. Among authors: cai jl. Br J Haematol. 2024 May 29. doi: 10.1111/bjh.19551. Online ahead of print. Br J Haematol. 2024. PMID: 38808512 No abstract available.
Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Othman T, Koller P, Tsai NC, Yang D, Pourhassan H, Agrawal V, Ngo D, Chen J, Farol L, Spielberger R, Sahebi F, Al Malki MM, Cai JL, Sandhu KS, Mansour J, Salhotra A, Ali H, Aribi A, Arslan S, Marcucci G, Forman SJ, Stein AS, Nakamura R, Pullarkat V, Aldoss I, Mei M. Othman T, et al. Among authors: cai jl. Am J Hematol. 2024 May 28. doi: 10.1002/ajh.27378. Online ahead of print. Am J Hematol. 2024. PMID: 38804599
Real-world experience of axicabtagene ciloleucel, a CD19-directed CAR T-cell therapy, in the second-line treatment of early relapsed or primary refractory large B-cell lymphoma.
Othman T, Baird JH, Pak S, Mei M, Herrera AF, Mansour J, Shouse G, Sahebi F, Spielberger R, Cai JL, Farol L, Godfrey J, Kallam A, Phillips T, Popplewell L, Siddiqi T, Forman S, Budde LE. Othman T, et al. Among authors: cai jl. Br J Haematol. 2024 May 26. doi: 10.1111/bjh.19521. Online ahead of print. Br J Haematol. 2024. PMID: 38797530 No abstract available.
Phase 1 Study of Bortezomib, Fludarabine, and Melphalan, With or Without Total Marrow Irradiation, as Allogeneic Hematopoietic Stem Cell Transplant Conditioning for High-risk or Relapsed/Refractory Multiple Myeloma.
Ladbury C, Sanchez J, Chowdhury A, Palmer J, Liu A, Stein A, Htut M, Farol L, Cai JL, Somlo G, Rosenzweig M, Wong JC, Sahebi F. Ladbury C, et al. Among authors: cai jl. Am J Clin Oncol. 2024 Mar 14. doi: 10.1097/COC.0000000000001095. Online ahead of print. Am J Clin Oncol. 2024. PMID: 38483213
Efficacy of adalimumab combined with Tripterygium wilfordii Hook F in the treatment of patient with rheumatoid arthritis: A multicenter, open-label, randomized-controlled trial.
Luo F, Gau SY, Wu YX, Liao HL, Tang F, Zhong Q, Huang Y, Hou L, Liu ZQ, Cai JL, Cao YP, Lu DM, An Y, Lan WY, Liu C, Chen CM, Jia ET, Yao XM, Wei JC, Ma WK. Luo F, et al. Among authors: cai jl. Int J Rheum Dis. 2024 Jan;27(1):e15031. doi: 10.1111/1756-185X.15031. Int J Rheum Dis. 2024. PMID: 38287544 Clinical Trial.
119 results